ELVN Stock Price
ELVN
ELVN stock price is $49.43 (+10.36% on the day), giving ELVN a market cap of $3.28B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ELVN Stock Overview
- Price
- $49.43
- Previous close
- $44.79
- Open
- $46.19
- Market cap
- $3.28B
- 1-year price target
- $73.15
- MarketXLS Rank
- 49
About ELVN
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a CNS penetrant and irreversible HER2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 driven cancers and solid tumors. The company is headquartered in Boulder, Colorado.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELVN | $49.43 | +10.4% | 969.64K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |